APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimicrobial Peptides

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Selected research

Industry Growth & Trends

Global Antimicrobial Peptides Industry Growth and Trends Forecast to 2032

1 January 2026102 pages

Choose your research edition.

Industry ResearchAntimicrobial Peptides Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimicrobial Peptides Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Antimicrobial Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimicrobial Peptides Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimicrobial Peptides Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

By region, North America had the highest share of sales, at about 35%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Antimicrobial Peptides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antimicrobial Peptides market size, estimates, and forecasts are presented in terms of sales volume (Mg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antimicrobial Peptides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antimicrobial Peptides.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antimicrobial Peptides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antimicrobial Peptides Market by Company

AnaSpec

AMP Biotech

Phoenix Biotech

Novabiotics

Chinese Peptide

Ontores

GenScript

Hycult Biotech

Sunsmile

Ruixing Biotechnology

Zhongnong Yingtai Biotechnology

Glam Technology

ProteLight Pharmaceutical & Biotechnology

Antimicrobial Peptides Segment by Type

Plant Antimicrobial Peptides

Microbial Antimicrobial Peptides

Animal Antimicrobial Peptides

Antimicrobial Peptides Segment by Application

Pharmaceuticals

Feed Additives

Others

Antimicrobial Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimicrobial Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimicrobial Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimicrobial Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antimicrobial Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Plant Antimicrobial Peptides Table 2. Major Company of Microbial Antimicrobial Peptides Table 3. Major Company of Animal Antimicrobial Peptides Table 4. Global Antimicrobial Peptides Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 6. Global Antimicrobial Peptides Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antimicrobial Peptides Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antimicrobial Peptides Sales Market Share in Value by Type (2021-2026) Table 9. Global Antimicrobial Peptides Price by Type (2021-2026) & (US$/Mg) Table 10. Global Antimicrobial Peptides Sales by Type (2027-2032) & (Mg) Table 11. Global Antimicrobial Peptides Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antimicrobial Peptides Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antimicrobial Peptides Sales Market Share in Value by Type (2027-2032) Table 14. Global Antimicrobial Peptides Price by Type (2027-2032) & (US$/Mg) Table 15. North America Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 16. North America Antimicrobial Peptides Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 18. Europe Antimicrobial Peptides Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 20. Asia-Pacific Antimicrobial Peptides Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 22. Latin America Antimicrobial Peptides Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antimicrobial Peptides Sales by Type (2021-2026) & (Mg) Table 24. Middle East and Africa Antimicrobial Peptides Sales by Type (2021-2026) & (US$ Million) Table 25. Antimicrobial Peptides Industry Trends Table 26. Antimicrobial Peptides Industry Drivers Table 27. Antimicrobial Peptides Industry Opportunities and Challenges Table 28. Antimicrobial Peptides Industry Restraints Table 29. Global Antimicrobial Peptides Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antimicrobial Peptides Revenue Market Share by Company (2021-2026) Table 31. Global Antimicrobial Peptides Sales by Company (2021-2026) & (Mg) Table 32. Global Antimicrobial Peptides Sales Share by Company (2021-2026) Table 33. Global Antimicrobial Peptides Market Price by Company (2021-2026) & (US$/Mg) Table 34. Global Antimicrobial Peptides Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antimicrobial Peptides Major Company Production Sites and Headquarters Table 36. Global Antimicrobial Peptides Company, Product Type & Application Table 37. Global Antimicrobial Peptides Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antimicrobial Peptides Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antimicrobial Peptides Sales by Region (2021-2026) & (Mg) Table 42. Global Antimicrobial Peptides Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antimicrobial Peptides Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antimicrobial Peptides Sales Market Share in Value by Region (2021-2026) Table 45. Global Antimicrobial Peptides Sales (Mg), Value (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 46. Global Antimicrobial Peptides Sales by Region (2027-2032) & (Mg) Table 47. Global Antimicrobial Peptides Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antimicrobial Peptides Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antimicrobial Peptides Sales Market Share in Value by Region (2027-2032) Table 50. Global Antimicrobial Peptides Sales (Mg), Value (US$ Million), Price (US$/Mg) and Gross Margin (2027-2032) Table 51. Global Antimicrobial Peptides Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 53. Global Antimicrobial Peptides Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antimicrobial Peptides Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antimicrobial Peptides Sales Market Share in Value by Application (2021-2026) Table 56. Global Antimicrobial Peptides Price by Application (2021-2026) & (US$/Mg) Table 57. Global Antimicrobial Peptides Sales by Application (2027-2032) & (Mg) Table 58. Global Antimicrobial Peptides Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antimicrobial Peptides Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antimicrobial Peptides Sales Market Share in Value by Application (2027-2032) Table 61. Global Antimicrobial Peptides Price by Application (2027-2032) & (US$/Mg) Table 62. North America Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 63. North America Antimicrobial Peptides Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 65. Europe Antimicrobial Peptides Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 67. Asia-Pacific Antimicrobial Peptides Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 69. Latin America Antimicrobial Peptides Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antimicrobial Peptides Sales by Application (2021-2026) & (Mg) Table 71. Middle East and Africa Antimicrobial Peptides Sales by Application (2021-2026) & (US$ Million) Table 72. AnaSpec Company Information Table 73. AnaSpec Business Overview Table 74. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 75. AnaSpec Antimicrobial Peptides Product Portfolio Table 76. AnaSpec Recent Development Table 77. AMP Biotech Company Information Table 78. AMP Biotech Business Overview Table 79. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 80. AMP Biotech Antimicrobial Peptides Product Portfolio Table 81. AMP Biotech Recent Development Table 82. Phoenix Biotech Company Information Table 83. Phoenix Biotech Business Overview Table 84. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 85. Phoenix Biotech Antimicrobial Peptides Product Portfolio Table 86. Phoenix Biotech Recent Development Table 87. Novabiotics Company Information Table 88. Novabiotics Business Overview Table 89. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 90. Novabiotics Antimicrobial Peptides Product Portfolio Table 91. Novabiotics Recent Development Table 92. Chinese Peptide Company Information Table 93. Chinese Peptide Business Overview Table 94. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 95. Chinese Peptide Antimicrobial Peptides Product Portfolio Table 96. Chinese Peptide Recent Development Table 97. Ontores Company Information Table 98. Ontores Business Overview Table 99. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 100. Ontores Antimicrobial Peptides Product Portfolio Table 101. Ontores Recent Development Table 102. GenScript Company Information Table 103. GenScript Business Overview Table 104. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 105. GenScript Antimicrobial Peptides Product Portfolio Table 106. GenScript Recent Development Table 107. Hycult Biotech Company Information Table 108. Hycult Biotech Business Overview Table 109. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 110. Hycult Biotech Antimicrobial Peptides Product Portfolio Table 111. Hycult Biotech Recent Development Table 112. Sunsmile Company Information Table 113. Sunsmile Business Overview Table 114. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 115. Sunsmile Antimicrobial Peptides Product Portfolio Table 116. Sunsmile Recent Development Table 117. Ruixing Biotechnology Company Information Table 118. Ruixing Biotechnology Business Overview Table 119. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 120. Ruixing Biotechnology Antimicrobial Peptides Product Portfolio Table 121. Ruixing Biotechnology Recent Development Table 122. Zhongnong Yingtai Biotechnology Company Information Table 123. Zhongnong Yingtai Biotechnology Business Overview Table 124. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 125. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio Table 126. Zhongnong Yingtai Biotechnology Recent Development Table 127. Glam Technology Company Information Table 128. Glam Technology Business Overview Table 129. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 130. Glam Technology Antimicrobial Peptides Product Portfolio Table 131. Glam Technology Recent Development Table 132. ProteLight Pharmaceutical & Biotechnology Company Information Table 133. ProteLight Pharmaceutical & Biotechnology Business Overview Table 134. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2021-2026) Table 135. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio Table 136. ProteLight Pharmaceutical & Biotechnology Recent Development Table 137. North America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (Mg): 2021 VS 2025 VS 2032 Table 138. North America Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 139. North America Antimicrobial Peptides Sales Market Share by Country (2021-2026) Table 140. North America Antimicrobial Peptides Sales Forecast by Country (2027-2032) & (Mg) Table 141. North America Antimicrobial Peptides Sales Market Share Forecast by Country (2027-2032) Table 142. North America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Antimicrobial Peptides Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Antimicrobial Peptides Market Share by Country (2021-2026) Table 145. North America Antimicrobial Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Antimicrobial Peptides Market Share Forecast by Country (2027-2032) Table 147. Europe Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (Mg): 2021 VS 2025 VS 2032 Table 148. Europe Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 149. Europe Antimicrobial Peptides Sales Market Share by Country (2021-2026) Table 150. Europe Antimicrobial Peptides Sales Forecast by Country (2027-2032) & (Mg) Table 151. Europe Antimicrobial Peptides Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Antimicrobial Peptides Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Antimicrobial Peptides Market Share by Country (2021-2026) Table 155. Europe Antimicrobial Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Antimicrobial Peptides Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (Mg): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 159. Asia-Pacific Antimicrobial Peptides Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Antimicrobial Peptides Sales Forecast by Country (2027-2032) & (Mg) Table 161. Asia-Pacific Antimicrobial Peptides Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Antimicrobial Peptides Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Antimicrobial Peptides Market Share by Country (2021-2026) Table 165. Asia-Pacific Antimicrobial Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Antimicrobial Peptides Market Share Forecast by Country (2027-2032) Table 167. Latin America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (Mg): 2021 VS 2025 VS 2032 Table 168. Latin America Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 169. Latin America Antimicrobial Peptides Sales Market Share by Country (2021-2026) Table 170. Latin America Antimicrobial Peptides Sales Forecast by Country (2027-2032) & (Mg) Table 171. Latin America Antimicrobial Peptides Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Antimicrobial Peptides Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Antimicrobial Peptides Market Share by Country (2021-2026) Table 175. Latin America Antimicrobial Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Antimicrobial Peptides Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (Mg): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Antimicrobial Peptides Sales by Country (2021-2026) & (Mg) Table 179. Middle East and Africa Antimicrobial Peptides Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Antimicrobial Peptides Sales Forecast by Country (2027-2032) & (Mg) Table 181. Middle East and Africa Antimicrobial Peptides Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Antimicrobial Peptides Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Antimicrobial Peptides Market Share by Country (2021-2026) Table 185. Middle East and Africa Antimicrobial Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Antimicrobial Peptides Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Antimicrobial Peptides Distributors List Table 190. Antimicrobial Peptides Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Antimicrobial Peptides Image Figure 2. Global Antimicrobial Peptides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimicrobial Peptides Market Size (2021-2032) & (US$ Million) Figure 4. Global Antimicrobial Peptides Sales (2021-2032) & (Mg) Figure 5. Plant Antimicrobial Peptides Image Figure 6. Global Plant Antimicrobial Peptides Sales YoY Growth (2021-2032) & (Mg) Figure 7. Microbial Antimicrobial Peptides Image Figure 8. Global Microbial Antimicrobial Peptides Sales YoY Growth (2021-2032) & (Mg) Figure 9. Animal Antimicrobial Peptides Image Figure 10. Global Animal Antimicrobial Peptides Sales YoY Growth (2021-2032) & (Mg) Figure 11. Global Antimicrobial Peptides Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antimicrobial Peptides Market Share by Type 2025 VS 2032 Figure 13. North America Antimicrobial Peptides Sales Market Share in Volume by Type in 2025 Figure 14. North America Antimicrobial Peptides Sales Market Share in Value by Type in 2025 Figure 15. Europe Antimicrobial Peptides Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antimicrobial Peptides Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antimicrobial Peptides Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antimicrobial Peptides Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antimicrobial Peptides Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antimicrobial Peptides Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Pharmaceuticals Image Figure 26. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (Mg) Figure 27. Feed Additives Image Figure 28. Global Feed Additives Sales YoY Growth (2021-2032) & (Mg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Mg) Figure 31. Global Antimicrobial Peptides Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Antimicrobial Peptides Market Share by Application 2025 VS 2032 Figure 33. North America Antimicrobial Peptides Sales Market Share in Volume by Application in 2025 Figure 34. North America Antimicrobial Peptides Sales Market Share in Value by Application in 2025 Figure 35. Europe Antimicrobial Peptides Sales Market Share in Volume by Application in 2025 Figure 36. Europe Antimicrobial Peptides Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Antimicrobial Peptides Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Antimicrobial Peptides Sales Market Share in Value by Application in 2025 Figure 39. Latin America Antimicrobial Peptides Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Antimicrobial Peptides Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Antimicrobial Peptides Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Antimicrobial Peptides Sales Market Share in Value by Application in 2025 Figure 43. North America Antimicrobial Peptides Sales by Country: 2021 VS 2025 VS 2032 (Mg) Figure 44. North America Antimicrobial Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Antimicrobial Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antimicrobial Peptides Sales by Country: 2021 VS 2025 VS 2032 (Mg) Figure 48. Europe Antimicrobial Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Antimicrobial Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antimicrobial Peptides Sales by Country: 2021 VS 2025 VS 2032 (Mg) Figure 52. Asia-Pacific Antimicrobial Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Antimicrobial Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antimicrobial Peptides Sales by Country: 2021 VS 2025 VS 2032 (Mg) Figure 56. Latin America Antimicrobial Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Antimicrobial Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antimicrobial Peptides Sales by Country: 2021 VS 2025 VS 2032 (Mg) Figure 60. Middle East and Africa Antimicrobial Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antimicrobial Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Antimicrobial Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Antimicrobial Peptides Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Antimicrobial Peptides Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Antimicrobial Peptides
  • Microbial Antimicrobial Peptides
  • Animal Antimicrobial Peptides
Applications
  • Pharmaceuticals
  • Feed Additives
  • Others
Companies covered
  • AnaSpec
  • AMP Biotech
  • Phoenix Biotech
  • Novabiotics
  • Chinese Peptide
  • Ontores
  • GenScript
  • Hycult Biotech
  • Sunsmile
  • Ruixing Biotechnology
  • Zhongnong Yingtai Biotechnology
  • Glam Technology
  • ProteLight Pharmaceutical & Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antimicrobial Peptides Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antimicrobial Peptides Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antimicrobial Peptides Market by Type
  6. 1.3.1 Plant Antimicrobial Peptides
  7. 1.3.2 Microbial Antimicrobial Peptides
  8. 1.3.3 Animal Antimicrobial Peptides
  9. 1.4 Global Antimicrobial Peptides Market Size by Type
  10. 1.4.1 Global Antimicrobial Peptides Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antimicrobial Peptides Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antimicrobial Peptides Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antimicrobial Peptides Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antimicrobial Peptides Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antimicrobial Peptides Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antimicrobial Peptides Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antimicrobial Peptides Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antimicrobial Peptides Industry Trends
  2. 2.2 Antimicrobial Peptides Industry Drivers
  3. 2.3 Antimicrobial Peptides Industry Opportunities and Challenges
  4. 2.4 Antimicrobial Peptides Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antimicrobial Peptides Revenue (2021-2026)
  2. 3.2 Global Top Players by Antimicrobial Peptides Sales (2021-2026)
  3. 3.3 Global Top Players by Antimicrobial Peptides Price (2021-2026)
  4. 3.4 Global Antimicrobial Peptides Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antimicrobial Peptides Major Company Production Sites & Headquarters
  6. 3.6 Global Antimicrobial Peptides Company, Product Type & Application
  7. 3.7 Global Antimicrobial Peptides Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antimicrobial Peptides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antimicrobial Peptides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antimicrobial Peptides Tier 1, Tier 2, and Tier 3
4 Antimicrobial Peptides Regional Status and Outlook
  1. 4.1 Global Antimicrobial Peptides Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antimicrobial Peptides Historic Market Size by Region
  3. 4.2.1 Global Antimicrobial Peptides Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antimicrobial Peptides Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antimicrobial Peptides Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antimicrobial Peptides Forecasted Market Size by Region
  7. 4.3.1 Global Antimicrobial Peptides Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antimicrobial Peptides Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antimicrobial Peptides Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antimicrobial Peptides by Application
  1. 5.1 Antimicrobial Peptides Market by Application
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Feed Additives
  4. 5.1.3 Others
  5. 5.2 Global Antimicrobial Peptides Market Size by Application
  6. 5.2.1 Global Antimicrobial Peptides Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antimicrobial Peptides Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antimicrobial Peptides Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antimicrobial Peptides Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antimicrobial Peptides Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antimicrobial Peptides Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antimicrobial Peptides Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antimicrobial Peptides Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AnaSpec
  2. 6.1.1 AnaSpec Company Information
  3. 6.1.2 AnaSpec Business Overview
  4. 6.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AnaSpec Antimicrobial Peptides Product Portfolio
  6. 6.1.5 AnaSpec Recent Developments
  7. 6.2 AMP Biotech
  8. 6.2.1 AMP Biotech Company Information
  9. 6.2.2 AMP Biotech Business Overview
  10. 6.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AMP Biotech Antimicrobial Peptides Product Portfolio
  12. 6.2.5 AMP Biotech Recent Developments
  13. 6.3 Phoenix Biotech
  14. 6.3.1 Phoenix Biotech Company Information
  15. 6.3.2 Phoenix Biotech Business Overview
  16. 6.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Phoenix Biotech Antimicrobial Peptides Product Portfolio
  18. 6.3.5 Phoenix Biotech Recent Developments
  19. 6.4 Novabiotics
  20. 6.4.1 Novabiotics Company Information
  21. 6.4.2 Novabiotics Business Overview
  22. 6.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novabiotics Antimicrobial Peptides Product Portfolio
  24. 6.4.5 Novabiotics Recent Developments
  25. 6.5 Chinese Peptide
  26. 6.5.1 Chinese Peptide Company Information
  27. 6.5.2 Chinese Peptide Business Overview
  28. 6.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chinese Peptide Antimicrobial Peptides Product Portfolio
  30. 6.5.5 Chinese Peptide Recent Developments
  31. 6.6 Ontores
  32. 6.6.1 Ontores Company Information
  33. 6.6.2 Ontores Business Overview
  34. 6.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ontores Antimicrobial Peptides Product Portfolio
  36. 6.6.5 Ontores Recent Developments
  37. 6.7 GenScript
  38. 6.7.1 GenScript Company Information
  39. 6.7.2 GenScript Business Overview
  40. 6.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GenScript Antimicrobial Peptides Product Portfolio
  42. 6.7.5 GenScript Recent Developments
  43. 6.8 Hycult Biotech
  44. 6.8.1 Hycult Biotech Company Information
  45. 6.8.2 Hycult Biotech Business Overview
  46. 6.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hycult Biotech Antimicrobial Peptides Product Portfolio
  48. 6.8.5 Hycult Biotech Recent Developments
  49. 6.9 Sunsmile
  50. 6.9.1 Sunsmile Company Information
  51. 6.9.2 Sunsmile Business Overview
  52. 6.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sunsmile Antimicrobial Peptides Product Portfolio
  54. 6.9.5 Sunsmile Recent Developments
  55. 6.10 Ruixing Biotechnology
  56. 6.10.1 Ruixing Biotechnology Company Information
  57. 6.10.2 Ruixing Biotechnology Business Overview
  58. 6.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Portfolio
  60. 6.10.5 Ruixing Biotechnology Recent Developments
  61. 6.11 Zhongnong Yingtai Biotechnology
  62. 6.11.1 Zhongnong Yingtai Biotechnology Company Information
  63. 6.11.2 Zhongnong Yingtai Biotechnology Business Overview
  64. 6.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio
  66. 6.11.5 Zhongnong Yingtai Biotechnology Recent Developments
  67. 6.12 Glam Technology
  68. 6.12.1 Glam Technology Company Information
  69. 6.12.2 Glam Technology Business Overview
  70. 6.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Glam Technology Antimicrobial Peptides Product Portfolio
  72. 6.12.5 Glam Technology Recent Developments
  73. 6.13 ProteLight Pharmaceutical & Biotechnology
  74. 6.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
  75. 6.13.2 ProteLight Pharmaceutical & Biotechnology Business Overview
  76. 6.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio
  78. 6.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America Antimicrobial Peptides Sales by Country
  2. 7.1.1 North America Antimicrobial Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antimicrobial Peptides Sales by Country (2021-2026)
  4. 7.1.3 North America Antimicrobial Peptides Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antimicrobial Peptides Market Size by Country
  6. 7.2.1 North America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antimicrobial Peptides Market Size by Country (2021-2026)
  8. 7.2.3 North America Antimicrobial Peptides Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antimicrobial Peptides Sales by Country
  2. 8.1.1 Europe Antimicrobial Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antimicrobial Peptides Sales by Country (2021-2026)
  4. 8.1.3 Europe Antimicrobial Peptides Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antimicrobial Peptides Market Size by Country
  6. 8.2.1 Europe Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antimicrobial Peptides Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antimicrobial Peptides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antimicrobial Peptides Sales by Country
  2. 9.1.1 Asia-Pacific Antimicrobial Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antimicrobial Peptides Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antimicrobial Peptides Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antimicrobial Peptides Market Size by Country
  6. 9.2.1 Asia-Pacific Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antimicrobial Peptides Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antimicrobial Peptides Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antimicrobial Peptides Sales by Country
  2. 10.1.1 South America Antimicrobial Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antimicrobial Peptides Sales by Country (2021-2026)
  4. 10.1.3 South America Antimicrobial Peptides Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antimicrobial Peptides Market Size by Country
  6. 10.2.1 South America Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antimicrobial Peptides Market Size by Country (2021-2026)
  8. 10.2.3 South America Antimicrobial Peptides Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antimicrobial Peptides Sales by Country
  2. 11.1.1 Middle East and Africa Antimicrobial Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antimicrobial Peptides Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antimicrobial Peptides Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antimicrobial Peptides Market Size by Country
  6. 11.2.1 Middle East and Africa Antimicrobial Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antimicrobial Peptides Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antimicrobial Peptides Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antimicrobial Peptides Value Chain Analysis
  2. 12.1.1 Antimicrobial Peptides Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antimicrobial Peptides Production Mode & Process
  7. 12.2 Antimicrobial Peptides Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antimicrobial Peptides Distributors
  10. 12.2.3 Antimicrobial Peptides Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst